Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
7
×
detroit top stories
glaxosmithkline
7
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
fda
amgen
clinical trials
abbvie
cancer
astrazeneca
bristol-myers squibb
cancer immunotherapy
duchenne muscular dystrophy
eli lilly
europe blog main
europe top stories
What
roundup
bio
days
abbvie’s
biotech
cancer
conference
day
labor
news
opioid
according
ahead
akcea
alliance
annual
ash
august
barbecuing
barcelona
biofourmis
black
bristol
bucks
busy
buy
calls
camping
cardiologist
cases
celebrate
center
centers
chance
changing
check
cholesterol
cigarettes
clinical
color
Language
unset
7
×
Current search:
unset
×
glaxosmithkline
×
" detroit blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
ESMO 2019: PARP and Prostate, SeaGen’s Win, KRAS Update & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More